Author:
Beck Benjamin H.,Kim Hyung-Gyoon,Kim Hyunki,Samuel Sharon,Liu Zhiyong,Shrestha Robin,Haines Hilary,Zinn Kurt,Lopez Richard D.
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Alam SM, Clark JS, Leech V, Whitford P, George WD, Campbell AM (1992) T cell receptor gamma/delta expression on lymphocyte populations of breast cancer patients. Immunol Lett 31:279–283
2. Aslakson CJ, Miller FR (1992) Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 52:1399–1405
3. Bank I, Book M, Huszar M, Baram Y, Schnirer I, Brenner H (1993) V delta 2+ gamma delta T lymphocytes are cytotoxic to the MCF 7 breast carcinoma cell line and can be detected among the T cells that infiltrate breast tumors. Clin Immunol Immunopathol 67:17–24
4. Bennouna J, Bompas E, Neidhardt EM, Rolland F, Philip I, Galea C, Salot S, Saiagh S, Audrain M, Rimbert M, Lafaye-de Micheaux S, Tiollier J, Negrier S (2008) Phase-I study of Innacell gammadelta, an autologous cell-therapy product highly enriched in gamma9delta2 T lymphocytes, in combination with IL-2, in patients with metastatic renal cell carcinoma. Cancer Immunol Immunother 57:1599–1609
5. Buchsbaum DJ, Khazaeli MB, Axworthy DB, Schultz J, Chaudhuri TR, Zinn KR, Carpenter M, LoBuglio AF (2005) Intraperitoneal pretarget radioimmunotherapy with CC49 fusion protein. Clin Cancer Res 11:8180–8185
Cited by
57 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献